ClinicalTrials.gov
public full text
Public Domain
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
anemiacardiovascularchronicdisease-progressionhyperphosphatemiaironiron-deficiencyrenal-insufficiency
A 9-month randomized, double-blind, placebo-controlled study to compare the effect of fixed dose ferric citrate versus placebo in patients with advanced chronic kidney disease (eGFR ≤20 ml/min/1.73m2) on the composite endpoint of time to initiation of maintenance dialysis or all-cause mortality.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients#909365
- Supplementary Material for: Epidemiology and multimorbidity in hemodialysis patients at a tertiary care center in northern Mexico: implications for hospital-based adverse outcomes#329784
- A Study of Ferric Citrate to Improve Inflammation and Lipid Levels#862031
- A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis#253119
- A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis#217163
Record · ID 969000
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive